|
1
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
3
|
Perz JF, Armstrong GL, Farrington LA,
Hutin YJ and Bell BP: The contributions of hepatitis B virus and
hepatitis C virus infections to cirrhosis and primary liver cancer
worldwide. J Hepatol. 45:529–538. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schütte K, Bornschein J and Malfertheiner
P: Hepatocellular carcinoma - epidemiological trends and risk
factors. Dig Dis. 27:80–92. 2009.PubMed/NCBI
|
|
5
|
Stratton MR: Exploring the genomes of
cancer cells: progress and promise. Science. 331:1553–1558. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stratton MR, Campbell PJ and Futreal PA:
The cancer genome. Nature. 458:719–724. 2009. View Article : Google Scholar
|
|
7
|
Meyerson M, Gabriel S and Getz G: Advances
in understanding cancer genomes through second-generation
sequencing. Nat Rev Genet. 11:685–696. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sung WK, Zheng H, Li S, et al: Genome-wide
survey of recurrent HBV integration in hepatocellular carcinoma.
Nat Genet. 44:765–769. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li M, Zhao H, Zhang X, et al: Inactivating
mutations of the chromatin remodeling gene ARID2 in
hepatocellular carcinoma. Nat Genet. 43:828–829. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tao Y, Ruan J, Yeh SH, et al: Rapid growth
of a hepatocellular carcinoma and the driving mutations revealed by
cell-population genetic analysis of whole-genome data. Proc Natl
Acad Sci USA. 108:12042–12047. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Totoki Y, Tatsuno K, Yamamoto S, et al:
High-resolution characterization of a hepatocellular carcinoma
genome. Nat Genet. 43:464–469. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li H and Durbin R: Fast and accurate
long-read alignment with Burrows-Wheeler transform. Bioinformatics.
26:589–595. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li H, Handsaker B, Wysoker A, et al: The
sequence alignment/map format and SAMtools. Bioinformatics.
25:2078–2079. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Koboldt DC, Zhang Q, Larson DE, et al:
VarScan 2: somatic mutation and copy number alteration discovery in
cancer by exome sequencing. Genome Res. 22:568–576. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Choi Y, Sims GE, Murphy S, Miller JR and
Chan AP: Predicting the functional effect of amino acid
substitutions and indels. PLoS One. 7:e466882012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ng PC and Henikoff S: SIFT: predicting
amino acid changes that affect protein function. Nucleic Acids Res.
31:3812–3814. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hussain SP, Schwank J, Staib F, Wang XW
and Harris CC: TP53 mutations and hepatocellular carcinoma:
insights into the etiology and pathogenesis of liver cancer.
Oncogene. 26:2166–2176. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Imbeaud S, Ladeiro Y and Zucman-Rossi J:
Identification of novel oncogenes and tumor suppressors in
hepatocellular carcinoma. Semin Liver Dis. 30:75–86. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Staib F, Hussain SP, Hofseth LJ, Wang XW
and Harris CC: TP53 and liver carcinogenesis. Hum Mutat.
21:201–216. 2003. View Article : Google Scholar
|
|
20
|
Kew MC: Synergistic interaction between
aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis. Liver
Int. 23:405–409. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
22
|
Scorsone KA, Zhou YZ, Butel JS and Slagle
BL: p53 mutations cluster at codon 249 in hepatitis B
virus-positive hepatocellular carcinomas from China. Cancer Res.
52:1635–1638. 1992.PubMed/NCBI
|
|
23
|
Bressac B, Kew M, Wands J and Ozturk M:
Selective G to T mutations of p53 gene in hepatocellular carcinoma
from southern Africa. Nature. 350:429–431. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gouas DA, Shi H, Hautefeuille AH, et al:
Effects of the TP53 p.R249S mutant on proliferation and
clonogenic properties in human hepatocellular carcinoma cell lines:
interaction with hepatitis B virus X protein. Carcinogenesis.
31:1475–1482. 2010.
|
|
25
|
Ladomery M and Dellaire G: Multifunctional
zinc finger proteins in development and disease. Ann Hum Genet.
66:331–342. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Papavassiliou AG: Transcription factors:
structure, function, and implication in malignant growth.
Anticancer Res. 15:891–894. 1995.PubMed/NCBI
|
|
27
|
Hans MA, Müller M, Meyer-Ficca M, Bürkle A
and Küpper JH: Overexpression of dominant negative PARP interferes
with tumor formation of HeLa cells in nude mice: evidence for
increased tumor cell apoptosis in vivo. Oncogene. 18:7010–7015.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ai J, Huang H, Lv X, et al: FLNA and PGK1
are two potential markers for progression in hepatocellular
carcinoma. Cell Physiol Biochem. 27:207–216. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Scheel C, Onder T, Karnoub A and Weinberg
RA: Adaptation versus selection: the origins of metastatic
behavior. Cancer Res. 67:11476–11480. 2007. View Article : Google Scholar : PubMed/NCBI
|
